Novartis sees future beyond eye drops, bagging option to buy developer of drug delivery tech ntaylor Tue, 11/16/2021 – 09:22 More: Novartis sees future beyond eye drops, bagging option to buy developer of drug delivery tech Source: fierce
read moreVoluntary license agreement will allow generic versions of pill to be manufactured More: Pfizer signs deal to allow expanded use of COVID-19 treatment Source: News
read moreTreatment authorised for use in adults with COVID-19 who are at high-risk of progressing to severe disease More: EC approves Celltrion’s COVID-19 mAb Regkirona Source: News
read moreThe data was obtained by a Freedom of Information request, according to The Independent More: Report: UK disposed of 600,000 AZ vaccine doses after they passed expiry date Source: News
read moreAHA: J&J’s Invokana chases AZ’s Farxiga and Lilly’s Jardiance with phase 3 heart failure win fkansteiner Mon, 11/15/2021 – 14:54 More: AHA: J&J's Invokana chases AZ's Farxiga and Lilly's Jardiance with phase 3 heart failure win Source: fierce
read moreAHA: Eli Lilly and Boehringer Ingelheim’s Jardiance stays on its heart failure winning streak—this time in acute patients kdunleavy Mon, 11/15/2021 – 14:09 More: AHA: Eli Lilly and Boehringer Ingelheim's Jardiance stays on its heart failure winning streak—this time in
read more© 1994 - 2026 B.M. Pharmaceuticals